Gupta Sushim K, Pfeltz Richard F, Wilkinson Brian J, Gustafson John E
Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, USA.
BD Life Sciences, Microbiology Research and Development, Sparks, MD 21152, USA.
Antibiotics (Basel). 2022 Aug 3;11(8):1051. doi: 10.3390/antibiotics11081051.
Physiological experimentation, transcriptomics, and metabolomics were engaged to compare a fusidic acid-resistant mutant SH10001st-2 to its parent strain SH1000. SH10001st-2 harbored a mutation (H457Y) in the gene which encodes the fusidic acid target, elongation factor G, as well as mutations in a putative phage gene of unknown function. SH10001st-2 grew slower than SH1000 at three temperatures and had reduced coagulase activity, two indicators of the fitness penalty reported for -mediated fusidic acid- resistance in the absence of compensatory mutations. Despite the difference in growth rates, the levels of O consumption and CO production were comparable. Transcriptomic profiling revealed 326 genes were upregulated and 287 were downregulated in SH10001st-2 compared to SH1000. Cell envelope and transport and binding protein genes were the predominant functional categories of both upregulated and downregulated genes in SH10001st-2. Genes of virulence regulators, notably the and systems, were highly upregulated as were genes encoding capsule production. Contrary to what is expected of mid-exponential phase cells, genes encoding secreted virulence factors were generally upregulated while those for adhesion-associated virulence factors were downregulated in SH10001st-2. Metabolomic analysis showed an overall increase in metabolite pools in SH10001st-2 compared to SH1000, mostly for amino acids and sugars. Slowed growth and metabolite accumulation may be byproducts of mutation-mediated protein synthesis impairment, but the overall results indicate that SH10001st-2 is compensating for the H457Y fitness penalty by repurposing its virulence machinery, in conjunction with increasing metabolite uptake capacity, in order to increase nutrient acquisition.
运用生理学实验、转录组学和代谢组学方法,将对夫西地酸耐药的突变体SH10001st - 2与其亲本菌株SH1000进行比较。SH10001st - 2在编码夫西地酸靶点延伸因子G的基因中存在一个突变(H457Y),同时在一个功能未知的假定噬菌体基因中也存在突变。在三个温度条件下,SH10001st - 2的生长速度均比SH1000慢,并且凝固酶活性降低,这是在没有补偿性突变的情况下,介导夫西地酸耐药所导致的适应性代价的两个指标。尽管生长速率存在差异,但氧气消耗和二氧化碳产生水平相当。转录组分析显示,与SH1000相比,SH10001st - 2中有326个基因上调,287个基因下调。细胞包膜、转运和结合蛋白基因是SH10001st - 2中上调和下调基因的主要功能类别。毒力调节因子的基因,尤其是和系统,以及编码荚膜产生的基因均高度上调。与对数中期细胞的预期情况相反,在SH10001st - 2中,编码分泌型毒力因子的基因普遍上调,而与黏附相关的毒力因子基因则下调。代谢组分析表明,与SH1000相比,SH10001st - 2中的代谢物库总体增加,主要是氨基酸和糖类。生长缓慢和代谢物积累可能是突变介导的蛋白质合成受损的副产品,但总体结果表明,SH10001st - 2正在通过重新利用其毒力机制,结合增加代谢物摄取能力,来补偿H457Y带来的适应性代价,以增加营养获取。